Skip to main content

Table 3 Summary of urine PK parameters (Amount excreted Ae) by treatment

From: The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis

Interval Salbutamol Treatment N Mean (μg) Median (μg) Min (μg) Max (μg) Median Percent of Dose (%)
0-30 min 1.5 μm (50 μg) 7 1.5 1.2 0.5 4 3
6 μm (50 μg) 7 1.2 1 0.7 2.8 2.4
Neb (2.5 mg) 7 17.4 14.4 0.7 46.3 0.7
pMDI (400 μg) 8 3.8 4.2 0.9 6.3 1
0-8 h 1.5 μm (50 μg) 6 8.1 6.9 2.7 19.4 16.2
6 μm (50 μg) 7 12.8 7.6 4.6 29.2 25.6
Neb (2.5 mg) 7 51.4 64.1 6.7 90.1 2.1
pMDI (400 μg) 8 16.5 17.6 4.5 28.7 4.1